Veracyte (VCYT) EBITDA Margin (2012 - 2026)
Veracyte's (VCYT) quarterly EBITDA Margin came in at 16.28% in Q1 2026, up 1375.0% year-on-year from 1.1% in Q1 2025, and down 38.43% quarter-over-quarter from 26.45% in Q4 2025.
Veracyte (VCYT) EBITDA Margin (2012 - 2026) Analysis & Trends
Veracyte has disclosed EBITDA Margin across 15 years of filings, most recently posting 16.28% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 16.28%, up 1375.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.31% (up 919.0% YoY), and the FY2025 annual result was 11.17%, up 755.0% from the prior year.
- EBITDA Margin came in at 16.28% for Q1 2026 at Veracyte, down from 26.45% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 26.45% in Q4 2025 to a low of 36.16% in Q4 2023.
- The 5-year median for EBITDA Margin is 4.81% (2024), against an average of 4.59%.
- Across the five-year window, EBITDA Margin soared 9158 bps in 2022 and plunged 2941 bps in 2023, its largest moves.
- Veracyte's EBITDA Margin stood at 6.75% in 2022, then tumbled by 436 bps to 36.16% in 2023, then soared by 110 bps to 3.52% in 2024, then jumped by 652 bps to 26.45% in 2025, then sank by 38 bps to 16.28% in 2026.
- The last three EBITDA Margin figures came in at 16.28% (Q1 2026), 26.45% (Q4 2025), and 17.4% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.21% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 19.42% |
| 10 | Veracyte | 3.75 Bn | 3.49 Bn | 101.16 Mn | 16.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.28% |
| Dec 31, 2025 | 26.45% |
| Sep 30, 2025 | 17.40% |
| Jun 30, 2025 | -4.05% |
| Mar 31, 2025 | 2.54% |
| Dec 31, 2024 | 3.52% |
| Sep 30, 2024 | 10.37% |
| Jun 30, 2024 | 4.03% |
| Mar 31, 2024 | -4.81% |
| Dec 31, 2023 | -36.16% |
| Sep 30, 2023 | -35.22% |
| Jun 30, 2023 | -8.91% |
| Mar 31, 2023 | -12.74% |
| Dec 31, 2022 | -6.75% |
| Sep 30, 2022 | -12.81% |
| Jun 30, 2022 | -14.73% |
| Mar 31, 2022 | -22.50% |
| Dec 31, 2021 | -18.32% |
| Sep 30, 2021 | -27.63% |
| Jun 30, 2021 | -16.40% |